Positive Signs As Multiple Insiders Buy Castle Biosciences Stock
Positive Signs As Multiple Insiders Buy Castle Biosciences Stock
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Castle Biosciences, Inc.'s (NASDAQ:CSTL) case, it's fantastic news for shareholders.
当一个内部人士购买股票时,通常是平淡无奇的。然而,当相当多的内部人士买入股票时,就像发生在城堡生物科学股份有限公司S纳斯达克(Sequoia Capital:CSTL)的案例,对股东来说是个极好的消息。
While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.
尽管就长期投资而言,内幕交易并不是最重要的事情,但我们确实认为,密切关注内部人士的所作所为是完全合乎逻辑的。
View our latest analysis for Castle Biosciences
查看我们对城堡生物科学的最新分析
The Last 12 Months Of Insider Transactions At Castle Biosciences
城堡生物科学公司最近12个月的内幕交易
The Independent Director Ellen Goldberg made the biggest insider purchase in the last 12 months. That single transaction was for US$69k worth of shares at a price of US$17.27 each. That means that an insider was happy to buy shares at above the current price of US$14.45. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.
独立董事艾伦·戈德堡在过去12个月里进行了最大规模的内部收购。这一笔交易是以每股17.27美元的价格收购了价值6.9万美元的股票。这意味着一位内部人士乐于以高于当前14.45美元的价格购买股票。尽管他们的观点可能在收购后发生了变化,但这至少表明他们对公司的未来充满信心。对我们来说,考虑内部人士为股票支付的价格非常重要。一般来说,如果内部人士以高于当前价格的价格买入一只股票,我们对这只股票的看法会更积极,因为这表明他们认为这只股票很有价值,即使价格更高。
While Castle Biosciences insiders bought shares during the last year, they didn't sell. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
尽管Castle Biosciences的内部人士在去年买入了股票,但他们没有卖出。你可以看到过去一年的内幕交易(由公司和个人),如下图所示。如果你想知道到底是谁卖了,卖了多少钱,什么时候卖的,只需点击下面的图表!
![insider-trading-volume](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231008/0-41767c90188d27fb98867d037500a9a8-0-905cda5d9a18bd9c1b1a9a53125b2179.png/big)
Castle Biosciences is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
内部人士买入的股票并不只是Castle Biosciences。所以让我们来看看这个免费内幕收购的成长型公司名单。
Insider Ownership
内部人持股
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. It appears that Castle Biosciences insiders own 3.4% of the company, worth about US$13m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.
看看一家公司的内部人持股总数,可以帮助你了解他们是否与普通股股东很好地结合在一起。我认为,如果内部人士持有该公司大量股份,这是一个好兆头。似乎Castle Biosciences内部人士拥有该公司3.4%的股份,价值约1300万美元。这种内部人持股水平是不错的,但还不够特别突出。这当然表明了一种合理的一致性。
So What Does This Data Suggest About Castle Biosciences Insiders?
那么,这些数据对城堡生物科学公司的内部人士有何启示?
There haven't been any insider transactions in the last three months -- that doesn't mean much. But insiders have shown more of an appetite for the stock, over the last year. Insiders do have a stake in Castle Biosciences and their transactions don't cause us concern. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. In terms of investment risks, we've identified 1 warning sign with Castle Biosciences and understanding this should be part of your investment process.
过去三个月没有发生任何内幕交易--这并不意味着什么。但在过去一年里,内部人士对该股表现出了更大的兴趣。内部人士确实持有Castle Biosciences的股份,他们的交易不会引起我们的担忧。因此,这些内幕交易可以帮助我们建立一个关于股票的论文,但了解这家公司面临的风险也是值得的。在投资风险方面,我们已经确定了1个警告信号有了城堡生物科学和理解,这应该是你投资过程的一部分。
Of course Castle Biosciences may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
当然了城堡生物科学公司可能不是最值得买入的股票。所以你可能想看看这个免费汇集了高质量的公司。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前只处理公开市场交易和私下处置直接权益,而不处理衍生工具交易或间接权益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。